Ishara Investments LP
CIK: 0002111609Latest portfolio: $87.5M · Q4 2025
Holdings
38
Total Value
$87.5M
New Positions
38
Closed Positions
0
Top Holdings
View All 38 Holdings →| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PRAXPRAXIS PRECISION MEDICINES I | 40,000 | $11.8M | 13.48% | |
| 2 | XERSXERIS BIOPHARMA HOLDINGS INC | 800,000 | $6.3M | 7.18% | |
| 3 | BMRNBIOMARIN PHARMACEUTICAL INC | 100,000 | $5.9M | 6.80% | |
| 4 | AM6AMICUS THERAPEUTICS INC | 360,000 | $5.1M | 5.86% | |
| 5 | ACADACADIA PHARMACEUTICALS INC | 160,000 | $4.3M | 4.89% | |
| 6 | ANNXANNEXON INC | 750,000 | $3.8M | 4.31% | |
| 7 | NUVBNUVATION BIO INC | 400,000 | $3.6M | 4.10% | |
| 8 | BBIOBRIDGEBIO PHARMA INC | 36,000 | $2.8M | 3.15% | |
| 9 | PTCTPTC THERAPEUTICS INC | 36,000 | $2.7M | 3.13% | |
| 10 | UTHUNITED THERAPEUTICS CORP DEL | 5,500 | $2.7M | 3.06% | |
| 11 | BCRXBIOCRYST PHARMACEUTICALS INC | 300,000 | $2.3M | 2.68% | |
| 12 | PCVXVAXCYTE INC | 50,000 | $2.3M | 2.64% | |
| 13 | GMABGENMAB A/S | 70,000 | $2.2M | 2.47% | |
| 14 | SNDXSYNDAX PHARMACEUTICALS INC | 100,000 | $2.1M | 2.40% | |
| 15 | VSTMVERASTEM INC | 270,000 | $2.1M | 2.38% | |
| 16 | TARSTARSUS PHARMACEUTICALS INC | 24,000 | $2.0M | 2.25% | |
| 17 | APOGAPOGEE ENTERPRISES INC | 25,000 | $1.9M | 2.16% | |
| 18 | ZNTLZENTALIS PHARMACEUTICALS INC | 1,320,000 | $1.8M | 2.04% | |
| 19 | IM8NINSMED INC | 10,000 | $1.7M | 1.99% | |
| 20 | HTDCORCEPT THERAPEUTICS INC | 44,000 | $1.5M | 1.75% | Call |
| 21 | SLNSILENCE THERAPEUTICS PLC | 240,000 | $1.5M | 1.67% | |
| 22 | EWTXEDGEWISE THERAPEUTICS INC | 58,000 | $1.4M | 1.65% | |
| 23 | BEAMBEAM THERAPEUTICS INC | 50,000 | $1.4M | 1.58% | |
| 24 | ORICORIC PHARMACEUTICALS INC | 160,000 | $1.3M | 1.50% | |
| 25 | APLSAPELLIS PHARMACEUTICALS INC | 50,000 | $1.3M | 1.44% |
Sector Breakdown
Healthcare0.0% ($1.178962805943427e+115T)
Unknown0.0% ($512.6T)
Industrials0.0% ($1.9M)
Financial Services0.0% ($1.5M)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | $87.5M | 38 |
Fund Information
Ishara Investments LP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $87.5M across 38 holdings. The largest position is PRAXIS PRECISION MEDICINES I (PRAX), representing 13.5% of the portfolio. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.